• Profile
Close

Evaluation of a new artificial tear formulation for the management of tear film stability and visual function in patients with dry eye

Clinical Ophthalmology Nov 02, 2017

Torkildsen G, et al. - Herein, a new artificial tear product, Rohto Dry-Aid was investigated for its ability to relieve the signs and symptoms of dry eye disease (DED). Comparable effects were reported by the two products, Rohto Dry-Aid and Systane Ultra, in terms of the signs and symptoms of DED. Although both products were designed to yield long-lasting relief, the Rohto group patients experienced a superior relief from discomfort related to visual tasking activities and daily diaries. This data suggested that the Rohto drops could present a longer duration of symptomatic relief over the course of the day.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay